CIVATECH ONCOLOGY, INC.

Company Information
Address 2810 MERIDIAN PKWY STE 148
DURHAM, NC, 27713-2234

http://www.civatechoncology.com

Information

DUNS: 801431862

# of Employees: 13


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers

    Amount: $1,464,585.00

    CivaTech Oncology s mission is to provide improved radiation therapy directly to localized tumors The Company has developed a novel polymer encapsulated membrane like radiation source that emits ra ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer

    Amount: $296,866.00

    CivaTech Oncology s mission is to provide improved radiation therapy directly to localized tumors The Company has developed a novel polymer encapsulated membrane like radiation source that emits ra ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  3. Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers

    Amount: $299,599.00

    CivaTech Oncology s mission is to provide improved radiation therapy directly to localized tumors The Company has developed a novel polymer encapsulated membrane like radiation source that emits ra ...

    SBIRPhase I2016Department of Health and Human Services
  4. IGF::OT::IGF OTHER FUNCTIONS DEVELOPMENT OF A UNI-DIRECTIONAL BRACHYTHERAPY DEVICE FOR THE TREATMENT OF NON-SMALL-CELL LUNG CANCER

    Amount: $998,964.00

    According to the American Cancer Society 220,000 men and women in the U.S. develop lung and bronchial cancer every year and 147,000 die of the disease. Of lung cancer patients, 85% present with non-sm ...

    SBIRPhase II2012Department of Health and Human Services
  5. Not Available

    Amount: $199,266.00

    The use of LDR brachytherapy after sub-lobar lung resection is the focus of a phase III NCI sponsored trial. Early clinical results from independent studies suggest that brachytherapy enables a singif ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government